Head of Global Access Scientific Communications

The Senior Director, Access Scientific Communications is a strategic scientific communications leader within the Global Data Dissemination organization, responsible for shaping and executing a comprehensive global communications strategy for Real-World Evidence (RWE) & Health Economics and Outcomes Research (HEOR) and Market Access initiatives. This role will translate complex evidence into high-quality, scientifically rigorous communications that advance understanding of the clinical, economic, humanistic, and real-world value of the company's medicines.

The role will partner closely within Medical, including Evidence Generation, as well as with stakeholders in Market Access, Clinical Development, Biostatistics, Commercial, and regional/local organizations to ensure evidence is effectively communicated across geographies and stakeholder audiences. The ideal candidate will leverage AI, analytics, automation, and digital technologies to improve planning, content development, data visualization and digital amplification, insight capture, and measurement.

The Senior Director will have global responsibility for the strategic development and oversight of peer-reviewed publications, congress communications, scientific platforms, evidence narratives, value and access materials, and other scientific content supporting evidence generation and market access objectives.

• Shape and lead the global Access Scientific Communications strategy across RWE/HEOR and Market Access across therapeutic areas, in collaboration with Medical and Market Access.
• Translate evidence generation strategies into integrated scientific communication plans spanning publications, congresses, scientific presentations, evidence narratives, digital channels, and other appropriate communication platforms.
• Establish strategic publication and communication priorities aligned with asset, disease area, evidence generation, and global access objectives.
• Ensure scientific communications effectively articulate the clinical, economic, humanistic, and real-world value of innovative medicines.
• Identify opportunities to communicate emerging evidence proactively and strategically across the product lifecycle.
• Develop frameworks for integrating evidence from clinical trials, RWE/HEOR, comparative effectiveness research, patient-reported outcomes, burden-of-illness studies, and other evidence sources.
• Establish metrics and KPIs to assess the quality, reach, engagement, and scientific impact of Access Scientific Communications.

• Provide strategic leadership for global publication planning and execution for RWE/HEOR, comparative effectiveness, and value/access evidence.
• Oversee development of high-quality manuscripts, abstracts, posters, oral presentations, and supplementary scientific materials.
• Ensure publication strategies appropriately reflect the evolving evidence landscape and scientific priorities across products and therapeutic areas.
• Partner with authors, investigators, external experts, and internal scientific teams to develop scientifically rigorous and impactful publications.
• Ensure adherence to applicable Good Publication Practice, ICMJE, GPP, Takeda's publication standards, and relevant regulatory/compliance requirements.
• Establish standards and best practices for communicating complex economic and real-world evidence to scientific and healthcare audiences.

• Partner with key stakeholders (Medical, Biostatistics, Market Access, and Clinical Development) to translate research programs into coherent communication strategies relevant to reimbursement, HTA, pricing, and access discussions.
• Proactively develop communication plans and content around prospective and retrospective RWE studies, database analyses, registries, pragmatic studies, comparative effectiveness research, economic models, patient outcomes, and healthcare resource utilization.
• Adapt global evidence communications for different healthcare systems, HTA environments, and geographic requirements while maintaining scientific consistency.
• Enable appropriate translation of global evidence into locally relevant scientific communications in collaboration with regional and country Market Access teams to support products' value proposition.
• Identify evidence gaps and communication opportunities that can inform future evidence generation strategies.
• Leverage AI, analytics,…